US Patent Issued to ACTIVE BIOTECH, THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY on March 24 for "Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy" (Swedish, American, French Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,643, issued on March 24, was assigned to ACTIVE BIOTECH AB (Lund, Sweden) and THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (Philadelphia).

"Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy" was invented by Yuliya Nefedova (Villanova, Pa.), Marie Torngren (Genarp, Sweden), Helena Eriksson (Torna-Hallestad, Sweden), Dmitry Gabrilovich (Villanova, Pa.) and Fabien Schmidlin (Mondeville, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and at least one further compound selected from a proteasome inhibitor, an immunomodulatory ...